Download - Fred Help Centre

MARCH 201 2
NEWSLETTER
April 2012 Price Reductions
The Pharmacy Guild of Australia has created, for members, an in-Store poster and a Stock Management
Spreadsheet to assist in the lead-up to the changes of the PBS Listings on 1 April 2012. To access these
resources members will need to:
• Log in to the Guild website to access the area reserved for members
• Click ‘Tools’ to find the documents required.
You will all have seen news of GSK’s pre-emptive strike on prices announced to commence 1 March 2012. The GSK items affected
are Amoxil; Aropax; Augmentin; Avandamet; Lamictal.
We recommend to all Fred Dispense clients the simple expedient of putting stickers onto your Dispensary shelves at the affected items
so that re-ordering can be closely monitored and stocks run down before the new wholesale prices come into effect.
Fred Office Customers
Material designed for Fred Office customers will be available on the Fred Help Centre to assist with these changes, this will show a list
of the items which will be affected by 1 April 2012 changes.
Labour Day Public Holiday
Monday 12 March 2012 is a public holiday in Victoria, Fred Help will still be available between
the hours of 8.30am to 9.00pm using the usual phone number 1300 731 888.
The Pharmacy Guild ScriptMAP
• Do you want the clearest available information on
changes to PBS pricing, including the official list of 1 April
2012 price changes, and indicative impact on your
pharmacy’s remuneration up to the end of the Fifth
Agreement?
• Would you like to better understand how to minimise any
adverse impact and what can be done to improve the
profitability of your pharmacy?
• Need to know where your pharmacy can improve generic
substitution and dispensing volumes?
The ScriptMAP-2015 report uses your own unique
dispensing data and the best available information to provide
a comprehensive, customised analysis of the impact of the
PBS Reforms, patent expiries, and changes to remuneration.
It also provides an Action List and guides you through
specific changes that may assist your pharmacy, with a focus
on generic substitution and dispensing volume growth.
ScriptMAP 2015 has recently been enhanced to include the
official list of 1 April 2012 price changes. The enhanced
version also includes a comprehensive year-by-year analysis
of the impact of PBS reforms and patent expires on your
pharmacy’s profitability up to the end of the 5th Agreement (201415).
Other features of ScriptMAP 2015 include estimates of top line
turnover growth and change in percentage gross profit, estimates
based on a range of volume growth outcomes (rather than just
one level), and a list of drugs where your generic substitution rate
is below the national average.
The comprehensive, personalised, 34 page ScriptMAP-2015
report is now available at a cost of just $90 plus GST for a single
report, or $270 plus GST for a 12 month subscription which
includes four reports and a customised ScriptMAP New Brands
Report every month. ScriptMAP is only available to Guild
members.
Guild Members are encouraged to take advantage of the
enhanced ScriptMAP 2015 to assist in understanding the full
impact of the 1 April 2012 price changes on your pharmacy’s
profitability.
The Guild ScriptMAP site is available for Guild members at
http://www.guild.org.au/scriptmap/
Fred Health Pty Ltd
20 Trenerry Crescent Abbotsford VIC 3067
T 03 9418 1800 Fred Help 1300 731 888 Local Call Cost F 1300 730 888
www.fred.com.au
A Fred IT Group Company
ScriptMAP Instructions with Fred Dispense
Guild ScriptMAP reports are generated from Fred Dispense via
ScriptMAP Generation, this is found at the bottom of the Fred
Dispense Activities menu <ALT+A>, <UP ARROW>.
The ScriptMAP Generation Screen, defaults to the previously
completed month and allows the pharmacy to enter their
preferred phone and email contact details.
Once these details are entered, clicking “Generate and Send”
will create the ScriptMAP.txt file which will automatically be
transmitted by Fred Connect (provided that the ScriptMAP
plugin is installed.)
Generally the Pharmacy Guild requires at least 2500 scripts to
generate the ScriptMAP report.
the following website to order their report.
https://www.guild.org.au/scriptmap/index.asp
Once the pharmacy has successfully transmitted this they go to
Features in Fred Dispense which may
be of Assistance
With the coming reductions in prices via the
PBS it seems a logical time to revisit two
‘Drug Management’ tasks in Fred Dispense
which may assist you in controlling your
stock, these are:
• Manage Stock Groups
• Manage Drug Ranking
The Drug Management feature has been designed to
allow pharmacies to quickly and easily manage drug
information within and between pharmacies.
It provides bulk creation and management of Stock Groups as
well as Drug Ranking. This is designed to assist easier
reporting (Stock Groups) as well as quicker dispensing (Drug
Ranking).
The Drug Management feature is available via the Activities
Menu <ALT + A><G> and can be turned on or off via Dispense
Options.
Manage Stock Groups <ALT + A><G><S>
Stock groups are a great way to manage drugs for effective Reporting (for instance by brand or manufacturer). To assist this process,
these groups are now able to be viewed and managed in bulk via “Manage Stock Groups”.
From “Manage Stock Groups” existing
stock groups can be selected via drop
down menus where as new stock groups
can be added by typing into these fields.
The drugs in the group are displayed in
the left hand side of the screen
www.fred.com.au
A Fred IT Group Company
The right hand side of screen allows drugs
to be added to the group by Manufacturer
or by specific selection.
Please note: the “Select All” and “Select
None” buttons are also available to speed
up specific drug selections.
Similar to the above addition, drugs can be
easily removed from a group using the
options on the left hand side of screen.
The current Stock Group for the drug displays
in the “Current Group” column.
A value of “0” indicates that the drug is
currently not part of a Stock Group.
Please note: drugs can only be part of one
Stock Group at a time.
www.fred.com.au
A Fred IT Group Company
Manage Drug Ranking<ALT + A><G><D>
By default drugs appear in alphabetical order during dispensing, however Drug Ranking allows this order to be adjusted to suit your
needs. More popular drugs can be “ranked” to appear first in the list, enabling fast drug selection during dispensing.
Similar to the Manage Stock Groups
function, “Manage Drug Ranking” allows
the addition of drugs via the right hand side
of screen and removal of drugs via the left.
The pull down allows you to select the Drug
Ranking (1-9) to focus on.
Please note:
• “1” is the highest possible rank a user
may set and “9” is the lowest possible
rank.
• “5” is considered unranked and is the
default rank for all drugs in Fred
Dispense.
• If you have run the Drug Usage Rank
Report, these drugs are given a “0” rank
and will always appear highest in the list
when dispensing.
The current Drug Ranking can be viewed
via the “Rank” columns.
Drugs can only have one “Rank”. If a drug
rank is removed, it will return to the default
rank of “5”.
Blank Labels and Name and address
We have had a number of reports that Medicare is possibly rejecting scripts if the name and
address of the Pharmacy does not appear on the coding sticker.
After discussions with Medicare we have been assured that, if blank labels are used, adding the Pharmacy stamp (with
location details) to the script when submitted will suffice.
The legislation, as far as we can interpret, does not seem to refer to the coding stocker, merely to the submitted
prescription.
www.fred.com.au
A Fred IT Group Company
MedView launches
March 2012
The much anticipated MedView trial will commence rollout in the coming weeks, with the first
sites having access to the new infrastructure in March 2012.
Participating healthcare professionals and patients in the Barwon Medicare Local region of Victoria will be the first of the
national sites to experience the benefits of a combined prescribed and dispensed medications information repository.
The benefits of MedView include:
• Combined prescribe and dispense information – see other medications prescribed and dispensed by participating
Healthcare professionals within the patient’s healthcare team.
• Fast, easy processing of scripts – the eRx script exchange platform ensures patient and drug information is
transferred quickly and securely into Fred Dispense fields.
• Script accuracy – no transcribing errors with information being loaded directly into the local patient fields, with the
option to clarify instructions if necessary.
• Safer – visibility over a patient’s combined prescribed and dispensed medications history gives you the ability to
monitor regime compliance and limit adverse drug interactions.
• Discharge information – See hospital discharge medications to ensure continuity of care.
• Efficient – giving you the time to focus on the patient’s broader needs. Consolidated information will assist you with
making informed suggestions for the sale of complimentary medicines and supporting products.
• Cost effective – no charge to install or use MedView.
What to do
As part of the Commonwealth Government’s eHealth program, all MedView participating healthcare providers across
Australia will need to ensure they have the following:
• A Health Provider Identifier for Organisations (HPI-O) allocated by the HI Service
• A Health Provider Identifier for Individuals (HPI-I) allocated by the HI Service
• eRx Script Exchange (essential for the participation in MedView)
Healthcare professionals in trial regions will be contacted directly regarding ‘Go Live’ dates in their specific areas.
Why do I need to apply for these?
You will need a HPI-O (and ultimately a HPI-I) for many of your dealings with Medicare, and the Federal Government
under the new Health Identifier (HI) Service. This will also enable you to access MedView, as well as further national
infrastructure and eHealth initiatives in the future.
You will need to have access to the HI service for Fred Dispense to validate the patient’s IHI (individual Health Identifier).
A valid patient IHI is necessary for consenting patient’s information to be uploaded to or viewed in MedView.
You need to be registered and using eRx Script Exchange to both contribute to and view medications information
through MedView.
How do I apply for these?
You should apply for your HPI-O via MediCare now so that you are ready for your dealing with the HI Service.
For more information on how to apply for your HPI-O and register for eRx and MedView, see the ‘How to Participate’
area of:
http://www.medview.com.au/healthcare-professionals or alternatively
http://www.medicareaustralia.gov.au/provider/health-identifier
www.fred.com.au
A Fred IT Group Company
HELP CENTRE
?
Have you missed a Webinar?
We have good news! All recorded Webinars can be viewed (or downloaded) at the following link:
https://help.fredhealth.com.au/tags/webinar/Recording/default.aspx
Please Note: You will need to be signed into the Fred Help Centre to access these files. Use the link in the very top right
hand corner to Sign In or Join the Fred Help Centre to access these.
FREE Fred Dispense Training!
Perfect for enhancing your skills as well as training new and existing staff or locums, the
new Fred Dispense Training CD offers over 3 hours’ worth of training completely FREE!
What is included in the Fred Dispense Training CD?
• The Dispensing Process
• Troubleshooting
• Fred Dispense Claiming & Updates
• The Fred Dispense Manual
• Tips & Tricks
How do I access more Online Training?
Sign up to the Fred Help Centre for access to over 600 documents and tutorials, hundreds of wiki pages, access to news blogs,
wholesaler promotion files, and the popular user forums where you can ask questions to other customers and provide Fred feedback.
Click on the following link to find out more: https://help.fredhealth.com.au/blogs/gettingstarted/pages/help.aspx
Fax this completed form to 1300 730 888 to order a Fred Dispense Training CD
Store Name
Store Address
State
Contact Name
Postcode
Position
Contact email
Attention CD delivery to: (if different from above)
Name
Position
Email
Please send me (tick all that apply)
n Fred Dispense Training CD
n Fred Office POS Touchscreen Training CD
n Fred Office Ordering & Pricing Upgrade Training CD (2.5 to 3.0)
n Fred Office Returns & Credits Training CD
n Alternatively, have a Sales Representative contact me to organise face to face training*
Further Comments
Priceline Pharmacies please note that
only the Fred Dispense Training CD
applies to you.
Please contact Priceline for your
Back Office training requirements.
* Charges apply for face to face training
www.fred.com.au
A Fred IT Group Company
Remember to scan the eRx barcode
eRx Script exchange continues to grow, with more
doctors and pharmacies coming online every day.
Remember to look for and scan the eRx barcode on the
duplicate side of original prescriptions. You will enjoy the
benefits of greater efficiencies through high speed receipt of
accurate prescription information and improve patient safety
through the reduction of transcription errors.
If you are not seeing eRx barcodes on doctors’ prescriptions
from your local surgeries then we encourage you to have a
chat with them about the benefits of eRx – or let us know and
we can contact them for you.
Should you have any questions or feedback, please don’t
hesitate to contact us at [email protected] or on
1300 700 921
Three Xbox’s up for grabs!!
Visit Fred on stand 123 & 128 at APP at the Gold Coast
Convention and Exhibition Centre, Qld; view a
demonstration of the latest Fred Office version and you
could win one of three Xbox 360TM consoles.
Register Now for the 2012 Season
Australia’s only on-line footy tipping competition for the pharmacy industry is back for Season 2012 of AFL
and NRL, with $5000 of weekly and end of season prizes up for grabs!
Register now for a chance to win a Sherrin AFL or Steeden NRL football. Every week until the AFL season kicks off on 24 March (the
NRL begins on 1 March) one PHARMeFOOTY registrant from each code will win a football.
Please visit www.pharmefooty.com.au to sign up today.
PBS Changes Effective March 2012
We have enclosed in this newsletter a summary of the important changes for your convenience. For the full Schedule of
Pharmaceutical Benefits visit http://www.pbs.gov.au/. This page enables you to search by the drug name in the schedule immediately.
www.fred.com.au
A Fred IT Group Company
PHARMACEUTICAL BENEFITS
These changes to the Schedule of Pharmaceutical Benefits are effective from 1 March 2012. The Schedule is updated on the
first day of each month and is available on the Internet at www.pbs.gov.au.
SUMMARY OF CHANGES
Additions
Addition – Item
3387G
Linagliptin, Tablet 5 mg (Trajenta)
2751T
2752W
1081X
8604W
8605X
8606Y
2502Q
2502Q
3058Y
3317N
3119E
3318P
1209P
1210Q
8220P
8703C
8700X
8701Y
8506Q
1434L
2848X
2849Y
2850B
2851C
2456G
2457H
2458J
8331L
8399C
8007K
8007K
8008L
8008L
2893G
5205Y
8470T
1978D
8787L
8869T
8789N
3169T
3170W
9079W
3171X
3172Y
2236Q
8836C
2237R
8837D
2011W
9242K
Addition – Brand
Auro‐Amlodipine 5, DO – Amlodipine, Tablet 5 mg (as besylate)
Auro‐Amlodipine 10, DO – Amlodipine, Tablet 10 mg (as besylate)
Atenolol‐PS, FZ – Atenolol, Tablet 50 mg
Bisoprolol Pfizer, FZ – Bisoprolol Fumarate, Tablet 2.5 mg
Bisoprolol Pfizer, FZ – Bisoprolol Fumarate, Tablet 5 mg
Bisoprolol Pfizer, FZ – Bisoprolol Fumarate, Tablet 10 mg
Calciprox, GN – Calcitriol, Capsule 0.25 microgram
Calcitriol‐PS, FZ – Calcitriol, Capsule 0.25 microgram
Cephalexin‐PS, FZ – Cephalexin, Capsule 250 mg
Cephalexin‐PS, FZ – Cephalexin, Capsule 250 mg (Dental)
Cephalexin‐PS, FZ – Cephalexin, Capsule 500 mg
Cephalexin‐PS, FZ – Cephalexin, Capsule 500 mg (Dental)
Ciprofloxacin‐PS, FZ – Ciprofloxacin, Tablet 500 mg
Ciprofloxacin‐PS, FZ – Ciprofloxacin, Tablet 750 mg
Auro‐Citalopram 20, DO – Citalopram Hydrobromide, Tablet 20 mg (base)
Auro‐Citalopram 40, DO – Citalopram Hydrobromide, Tablet 40 mg (base)
Escitalopram GA, GN – Escitalopram, Tablet 10 mg (as oxalate)
Escitalopram GA, GN – Escitalopram, Tablet 20 mg (as oxalate)
Exemestane Sandoz, SZ – Exemestane, Tablet 25 mg
Fluoxetine‐PS, FZ – Fluoxetine, Capsule 20 mg (as hydrochloride)
Lamotrigine‐PS, FZ – Lamotrigine, Tablet 25 mg
Lamotrigine‐PS, FZ – Lamotrigine, Tablet 50 mg
Lamotrigine‐PS, FZ – Lamotrigine, Tablet 100 mg
Lamotrigine‐PS, FZ – Lamotrigine, Tablet 200 mg
Lisinopril‐PS, FZ – Lisinopril, Tablet 5 mg
Lisinopril‐PS, FZ – Lisinopril, Tablet 10 mg
Lisinopril‐PS, FZ – Lisinopril, Tablet 20 mg
Omeprazole‐PS, FZ – Omeprazole, Tablet 20 mg
Pantoprazole‐PS, FZ – Pantoprazole Sodium Sesquihydrate, Tablet (enteric coated), equivalent to 20 mg pantoprazole
Panthron, GN – Pantoprazole Sodium Sesquihydrate, Tablet (enteric coated), equivalent to 40 mg pantoprazole
Pantoprazole‐PS, FZ – Pantoprazole Sodium Sesquihydrate, Tablet (enteric coated), equivalent to 40 mg pantoprazole
Panthron, GN – Pantoprazole Sodium Sesquihydrate, Tablet (enteric coated), equivalent to 40 mg pantoprazole
Pantoprazole‐PS, FZ – Pantoprazole Sodium Sesquihydrate, Tablet (enteric coated), equivalent to 40 mg pantoprazole
Prochlorperazine‐PS, FZ – Prochlorperazine, Tablet containing prochlorperazine maleate 5 mg
Prochlorperazine‐PS, FZ – Prochlorperazine, Tablet containing prochlorperazine maleate 5 mg (Dental)
Ramipril‐PS, FZ – Ramipril, Capsule 10 mg
Ranitidine‐PS, FZ – Ranitidine Hydrochloride, Tablet 150 mg (base)
Risperidone Pfizer, FZ – Risperidone, Tablet 0.5 mg
Risperidone Pfizer, FZ – Risperidone, Tablet 0.5 mg
Risperidone Pfizer, FZ – Risperidone, Tablet 1 mg
Risperidone Pfizer, FZ – Risperidone, Tablet 1 mg
Risperidone Pfizer, FZ – Risperidone, Tablet 2 mg
Risperidone Pfizer, FZ – Risperidone, Tablet 2 mg
Risperidone Pfizer, FZ – Risperidone, Tablet 3 mg
Risperidone Pfizer, FZ – Risperidone, Tablet 4 mg
Auro‐Sertraline 50, DO – Sertraline, Tablet 50 mg (as hydrochloride)
Auro‐Sertraline 50, DO – Sertraline, Tablet 50 mg (as hydrochloride)
Auro‐Sertraline 100, DO – Sertraline, Tablet 100 mg (as hydrochloride)
Auro‐Sertraline 100, DO – Sertraline, Tablet 100 mg (as hydrochloride)
Auro‐Simvastatin 10, DO – Simvastatin, Tablet 10 mg
Auro‐Simvastatin 10, DO – Simvastatin, Tablet 10 mg
2012X
9243L
8173E
9244M
8313M
9245N
Auro‐Simvastatin 20, DO – Simvastatin, Tablet 20 mg
Auro‐Simvastatin 20, DO – Simvastatin, Tablet 20 mg
Auro‐Simvastatin 40, DO – Simvastatin, Tablet 40 mg
Auro‐Simvastatin 40, DO – Simvastatin, Tablet 40 mg
Auro‐Simvastatin 80, DO – Simvastatin, Tablet 80 mg
Auro‐Simvastatin 80, DO – Simvastatin, Tablet 80 mg
8885P
Addition – Equivalence Indicator
Imigran FDT, GK – Sumatriptan, Tablet (fast disintegrating) 50 mg (as succinate)
8885P
Addition ‐Note
Denosumab, Injection 60 mg in 1 mL pre‐filled syringe (Prolia)
Sumatriptan, Tablet 50 mg (as succinate) (Imigran, Sumatab, Sumagran 50, Pharmacor Sumatriptan 50, APO‐Sumatriptan,
Chem mart Sumatriptan, Terry White Chemists Sumatriptan, Sumatriptan‐GA, Sumatriptan generichealth)
Sumatriptan, Tablet (fast disintegrating) 50 mg (as succinate) (Imigran FDT)
2502Q
1169M
5045M
1209P
1210Q
1370D
1368B
1369C
2487X
2848X
2849Y
2850B
2851C
2456G
2457H
2458J
2321E
2430X
1801T
2350Q
2349P
2242B
2833D
9237E
2834E
9238F
8197K
9239G
8259Q
9120B
9121C
9122D
8470T
1760P
5260W
8016X
5261X
2236Q
2237R
Deletions
Deletion – Brand
Calcitriol‐DP, GN – Calcitriol, Capsule 0.25 microgram
Douglas Cefaclor‐CD, GM – Cefaclor, Tablet 375 mg (sustained release)
Douglas Cefaclor‐CD, GM – Cefaclor, Tablet 375 mg (sustained release) (Dental)
Ascent Pharmaceuticals Limited, GN – Ciprofloxacin, Tablet 500 mg
Ascent Pharmaceuticals Limited, GN – Ciprofloxacin, Tablet 750 mg
Enalapril‐DP 5mg, GN – Enalapril, Tablet containing enalapril maleate 5 mg
Enalapril‐DP 10mg, GN – Enalapril, Tablet containing enalapril maleate 10 mg
Enalapril‐DP 20mg, GN – Enalapril, Tablet containing enalapril maleate 20 mg
Pepcidine M, MK – Famotidine, Tablet 20 mg
Lamotrigine‐DP, GM – Lamotrigine, Tablet 25 mg
Lamotrigine‐DP, GM – Lamotrigine, Tablet 50 mg
Lamotrigine‐DP, GM – Lamotrigine, Tablet 100 mg
Lamotrigine‐DP, GM – Lamotrigine, Tablet 200 mg
Liprace, GM – Lisinopril, Tablet 5 mg
Liprace, GM – Lisinopril, Tablet 10 mg
Liprace, GM – Lisinopril, Tablet 20 mg
Medroxyhexal, HX – Medroxyprogesterone Acetate, Tablet 10 mg
Ascent Pharmaceuticals Limited, GN – Metformin Hydrochloride, Tablet 500 mg
Ascent Pharmaceuticals Limited, GN – Metformin Hydrochloride, Tablet 850 mg
Karicare De‐Lact, SB – Milk Powder—lactose Free Formula, Lactose‐predigested powder infant formula 900 g
Karicare De‐Lact, SB – Milk Powder—lactose Free Formula, Lactose‐predigested powder infant formula 900 g
Paroxetine‐DP, GM – Paroxetine, Tablet 20 mg (as hydrochloride)
Pravastatin 10, MI – Pravastatin, Tablet containing pravastatin sodium 10 mg
Pravastatin 10, MI – Pravastatin, Tablet containing pravastatin sodium 10 mg
Pravastatin 20, MI – Pravastatin, Tablet containing pravastatin sodium 20 mg
Pravastatin 20, MI – Pravastatin, Tablet containing pravastatin sodium 20 mg
Pravastatin 40, MI – Pravastatin, Tablet containing pravastatin sodium 40 mg
Pravastatin 40, MI – Pravastatin, Tablet containing pravastatin sodium 40 mg
Pepti‐Junior Gold, SB – Protein Hydrolysate Formula with Medium Chain Triglycerides, Compound powder 450 g
Ramipril‐DP, GN – Ramipril, Capsule 1.25 mg
Ramipril‐DP, GN – Ramipril, Capsule 2.5 mg
Ramipril‐DP, GN – Ramipril, Capsule 5 mg
Ramipril‐DP, GN – Ramipril, Capsule 10 mg
Roxide, HX – Roxithromycin, Tablet 150 mg
Roxide, HX – Roxithromycin, Tablet 150 mg (Dental)
Roxide, HX – Roxithromycin, Tablet 300 mg
Roxide, HX – Roxithromycin, Tablet 300 mg (Dental)
Concorz, HX – Sertraline, Tablet 50 mg (as hydrochloride)
Concorz, HX – Sertraline, Tablet 100 mg (as hydrochloride)
5457F
8144P
2350Q
2349P
8259Q
Deletion – Equivalence Indicator
Karicare Aptamil De‐Lact, NU – Milk Powder—lactose Free Formula, Lactose‐predigested powder infant formula 900 g
Karicare Aptamil De‐Lact, NU – Milk Powder—lactose Free Formula, Lactose‐predigested powder infant formula 900 g
Karicare Aptamil Pepti‐Junior Gold, NU – Protein Hydrolysate Formula with Medium Chain Triglycerides,
Compound powder 450 g
Alterations
Alteration – Item Description
From:
9329B
To:
9329B
Essential Amino Acids Formula, Powder 200 g, 2 (Essential Amino Acid Mix)
Essential Amino Acids Formula, Powder 200 g (Essential Amino Acid Mix)
This alteration of form results in the increase to the maximum quantity for this item from 3 to 6.
5457F
3423E
3424F
Alteration – Restriction
Denosumab, Injection 60 mg in 1 mL pre‐filled syringe (Prolia)
Exenatide, Injection solution 5 micrograms per dose in pre‐filled pen, 60 doses (Byetta 5 microgram)
Exenatide, Injection solution 10 micrograms per dose in pre‐filled pen, 60 doses (Byetta 10 microgram)
Alteration – Authorised Prescriber
The following items can now be prescribed by Nurse Practitioners.
5285E
Amlodipine with Valsartan and Hydrochlorothiazide, Tablet 5 mg (as besylate)‐160 mg‐12.5 mg (Exforge HCT 5/160/12.5)
5286F
Amlodipine with Valsartan and Hydrochlorothiazide, Tablet 5 mg (as besylate)‐160 mg‐25 mg (Exforge HCT 5/160/25)
5287G
Amlodipine with Valsartan and Hydrochlorothiazide, Tablet 10 mg (as besylate)‐160 mg‐12.5 mg (Exforge HCT 10/160/12.5)
5288H
Amlodipine with Valsartan and Hydrochlorothiazide, Tablet 10 mg (as besylate)‐160 mg‐25 mg (Exforge HCT 10/160/25)
5289J
Amlodipine with Valsartan and Hydrochlorothiazide, Tablet 10 mg (as besylate)‐320 mg‐25 mg (Exforge HCT 10/320/25)
Alteration – Manufacturer's Code
8286D
Sandrena, AS – Oestradiol, Transdermal gel 1 mg in 1 g sachet, 28
From:
MK
To:
AS
REPATRIATION PHARMACEUTICAL BENEFITS
4277D
4050E
4286N
4275B
4252T
4255Y
4258D
4259E
4263J
4266M
4270R
4196W
4207K
4230P
4303L
4306P
3400Y
4307Q
4290T
4302K
4115N
4594T
4595W
4419N
4422R
4462W
Additions
Addition – Item
Alfuzosin Hydrochloride, Tablet 10 mg (Xatral SR)
Bandage—compression, Bandage, two layer (Coban)
Codeine Phosphate with Aspirin, Tablet 8 mg‐300 mg (Aspalgin 40)
Codeine Phosphate with Paracetamol, Tablet 8 mg‐500 mg (Panamax Co. 40)
Dressing—foam—silver, Dressings, adhesive, 7.5 cm x 7.5 cm, 10 (Allevyn Ag Adhesive 66800073)
Dressing—foam—silver, Dressings, adhesive, 10 cm x 10 cm, 10 (Allevyn Ag Adhesive 66800075)
Dressing—foam—silver, Dressings, adhesive, 12.5 cm x 12.5 cm, 10 (Allevyn Ag Adhesive 66800078)
Dressing—foam—silver, Dressings, non‐adhesive, 10 cm x 10 cm, 10 (Allevyn Ag Non‐Adhesive 66800086)
Dressing—foam—silver, Dressings 7.5 cm x 7.5 cm, 10 (Allevyn Ag Gentle 66800460)
Dressing—foam—silver, Dressings 10 cm x 10 cm, 10 (Allevyn Ag Gentle 66800461)
Dressing—foam—silver, Dressings 12.5 cm x 12.5 cm, 10 (Allevyn Ag Gentle 66800462)
Dressing—foam with Silicone—heavy Exudate, Dressings 10 cm x 10 cm, 10 (Allevyn Gentle 66800248)
Dressing—foam with Silicone—heavy Exudate, Dressings 7.5 cm x 7.5 cm, 10 (Allevyn Gentle Border 66800269)
Dressing—foam with Silicone—heavy Exudate, Dressings 10 cm x 10 cm, 10 (Allevyn Gentle Border 66800270)
Finasteride, Tablet 5 mg (Finpro)
Lubricating Gel, Tube 100 g (Lubri‐Gel)
Miconazole Nitrate, Cream 40 g (2% miconazole) (Resolve Thrush)
Sunscreens, Cream 75 g (Sunsense Sensitive SPF 30+)
Vardenafil, Tablet 10 mg (Levitra)
Vardenafil, Tablet 20 mg (Levitra)
Addition – Brand
Zedd 500, QA – Azithromycin, Tablet 500 mg (as dihydrate)
Gabatine 600, QA – Gabapentin, Tablet 600 mg
Gabatine 800, QA – Gabapentin, Tablet 800 mg
Fibre Health Orange Smooth Sugar Free, PP – Psyllium Hydrophilic Mucilloid, Oral powder (orange‐flavoured,
sugar‐free) 283 g
Fibre Health Natural Granular, PP – Psyllium Hydrophilic Mucilloid, Oral powder (non‐flavoured) 336 g
Micolette, AE – Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate, Enemas 3.125 g‐450 mg‐45 mg in 5 mL, 4
Alterations
Alteration – Item Description
From:
4935R
To:
4935R
Dressing with Cadexomer Iodine, Sachets 5 g (6 cm x 4 cm), 5 (Iodosorb 66051330)
Dressing with Cadexomer Iodine, Sheets 5 g (6 cm x 4 cm), 5 (Iodosorb 66051330)
From:
4937W
To:
4937W
From:
4481W
To:
4481W
Dressing with Cadexomer Iodine, Sachets 17 g (10 cm x 8 cm), 2 (Iodosorb 66051360)
Dressing with Cadexomer Iodine, Sheets 17 g (10 cm x 8 cm), 2 (Iodosorb 66051360)
Tolnaftate, Spray aerosol, 100 g (Tinaderm)
Tolnaftate, Spray aerosol 0.7 mg per g (0.07%), 100 g (Tinaderm)
Advance Notices
Advance Notices – Deletion of Item
The following items will be deleted from the Schedule of Pharmaceutical Benefits on 1 April 2012:
Item discontinued by the manufacturer—
8443J
3066J
Amino Acids—synthetic, Formula, Compound powder 400 g (Neocate)
Amino Acids—synthetic, Formula, Compound powder 400 g (Neocate)
The following items will be deleted from the Schedule of Pharmaceutical Benefits on 1 May 2012:
Item discontinued by the manufacturer—
5398D
5397C
1658G
Naproxen, Oral suspension 125 mg per 5 mL, 474 mL (Naprosyn)(Palliative Care)
Naproxen, Oral suspension 125 mg per 5 mL, 474 mL (Naprosyn)(Palliative Care)
Naproxen, Oral suspension 125 mg per 5 mL, 474 mL (Naprosyn)
Advance Notices – Deletion of Brand
The following brands will be deleted from the Schedule of Pharmaceutical Benefits on 1 April 2012:
Brand discontinued by the manufacturer—
1434L
8313M
9245N
Fluohexal, HX – Fluoxetine, Capsule 20 mg (as hydrochloride)
Simvahexal, HX – Simvastatin, Tablet 80 mg
Simvahexal, HX – Simvastatin, Tablet 80 mg
EFFICIENT FUNDING OF CHEMOTHERAPY
– SECTION 100 ARRANGEMENTS
SUMMARY OF CHANGES
The explanatory notes section of this schedule provides information on the prescribing and dispensing of chemotherapy drugs
under the Efficient Funding of Chemotherapy Drugs — Section 100 Arrangements.
In addition to the commencement of these new arrangements, the changes listed below take effect from 1 March 2012.
Additions
Addition – Form
Solution concentrate for I.V. infusion 200 mg (as hydrochloride) in 5 mL
(Gemcitabine Ebewe, SZ)
Solution concentrate for I.V. infusion 1 g (as hydrochloride) in 25 mL
(Gemcitabine Ebewe, SZ)
Solution concentrate for I.V. infusion 2 g (as hydrochloride) in 50 mL
(Gemcitabine Ebewe, SZ)
7246J,
4439P
7246J,
4439P
7246J,
4439P
Gemcitabine
Injection
Gemcitabine
Injection
Gemcitabine
Injection
7231N,
4375G
7231N,
4375G
7231N,
4375G
7231N,
4375G
7231N,
4375G
Epirubicin
Injection/ intravesical
Addition – Brand
Epirubicin Actavis 10, TA (Solution for injection 10 mg in 5 mL)
Epirubicin
Injection/ intravesical
Epirubicin Actavis 20, TA (Solution for injection 20 mg in 10 mL)
Epirubicin
Injection/intravesical
Epirubicin Actavis 50, TA (Solution for injection 50 mg in 25 mL)
Epirubicin
Injection/ intravesical
Epirubicin Actavis 100, TA (Solution for injection 100 mg in 50 mL)
Epirubicin
Injection/ intravesical
Epirubicin Actavis 200, TA (Solution for injection 200 mg in 100 mL)
Alterations
Alteration – Restriction
All forms of Gemcitabine are now unrestricted.
Alteration – Note
7246J,
4439P
Gemcitabine
Injection
MONTHLY UPDATE PROCEDURE FOR
Please tick 3 and initial when step is completed >
STEP 1
PERFORMING A BACKUP
A backup must be performed before running the Fred Dispense Monthly update. The pre-update backup takes a copy of the Fred Dispense data and
programs before you upgrade to a later version. It is recommended that this backup is taken away from the pharmacy and stored off-site.
It is recommended that you perform the backup after receiving the update notification email or before running Step 3 for the program update.
Please tick 3 and initial when step is completed >
STEP 2
DOWNLOAD UPDATE USING FRED CONNECT
Within 24 hours of receiving the Monthly Update Email Fred Connect automatically downloads the Fred Dispense
Update. Alternatively you can use Fred Connect to download the update manually
1. Right click on the Fred Connect icon
found in the system tray and left
click on Show
3. Left click on the Select Program Updates to
Download button. A window will appear
showing the list of updates available. Scroll to
the bottom of the list and tick the box next to
the update required. Left click the Download
Selected Updates button to begin
downloading the update.
2. Left click on the Plugins Tab then left click
on the Utility Configuration Tab
4. The Fred Connect program will switch to the
Downloads tab where the update download
progress is shown. At this time you may wish
to wait until the download completes.
Alternatively Fred Connect can be sent back to
the system tray by left clicking on the cross on
the top right hand side of the window. The
update will continue to download and
dispensing can continue.
Please tick 3 and initial when step is completed >
STEP 3
RUNNING THE PROGRAM UPDATE
The next time the Fred Dispense program is re-opened after the update has
downloaded; a prompt will appear to run the program update. At this point Fred
Dispense and Fred Connect should be exited on all computers.
1. Close Fred Dispense on all computers using <ALT + X>
2. Close Fred Connect by right clicking the Fred Connect icon
in the system tray and choosing STOP.
You can then choose YES to the prompt to run the program update.
You DO NOT need to wait until the end of the month to run the Program Update step.
Please tick 3 and initial when step is completed >
STEP 4
RUNNING THE DRUG UPDATE
This step is to be run after close of trade on the last trading day of the month.
1. Exit Fred Dispense and Fred Connect
on all computers
2. Left click on the Windows Start Menu and
choose Programs, Fred, Fred Dispense,
Drug Update.
3. After performing the drug update
Fred Dispense will run with new Drug details
and prices. This can be checked by pressing
<F7> Quick Drug Price lookup from
Fred Dispense and typing TEST <ENTER>
to check if the current month’s Test Drug is
displayed at the top of the screen.
If you are not receiving the monthly update notification email, make sure Fred Health has your current email address.
To advise us of any change to your email address please call Fred Help on 1300 731 888 or email [email protected]
25% OFF
AusDI Online and AusDI Mobile
for
iPhone and iPad!
*Normal subscription $295 excl. GST, offer expires 30th April 2012.
This offer is open to new customers only.
Evidence-based, independent, and comprehensive drug information
The comprehensive drug reference
2770 Product Information Sheets
2880 Consumer Medicines Information Leaflets
1100 Drug Product Monographs
2440 Drug Product Images
Features
Search for:
Full drug product information (PIs)
Drug product images searchable by colour, markings
and shape
Consumer medicines information (CMIs)
Full text, evidence-based drug, drug-class and
complementary drug product monographs
Patient counselling points
Patient monitoring recommendations
Indications
Precautions in geriatric patients and other patient
population groups
Contraindications
Side effects and symptoms
Dosage recommendations
Products not marketed in Australia
Pharmacy Board Listed Reference
A listed reference by the Pharmacy Board of Australia for:
Prescription products
Drug Interactions
Evidence-based reference work on complementary and
alternative medicines
Now integrated with
Available in the following formats
Our Partners
BY INTERNET: www.phoenixmedical.com.au/subscribe
PROMOTIONAL CODE: FRED0212
BY PHONE: Contact our AusDI Advanced Sales team on
1300 118 120 and quote “FRED0212”
BY FAX: Simply complete the form on the back
and fax to 02 9947 2547
AusDI Advanced Order Form
FAX BACK (02) 9947 2547
AusDI Advanced 1 Year online subscription*
Price
GST
$221.25
$22.13
* Single user licence - 25% off standard subscription of $295 excl. GST for new customers only. Offer expires 30th April 2012.
First Name
Quantity
$
TOTAL
Surname
Organisation
Address
Postcode
)
Tel
)
Fax
E-mail
Payment methods:
POST CHEQUE:
Payable to Health Communication Network Ltd
OR FAX:
Credit Card details on this form to: (02) 9947 2547
OR BY PHONE:
1300 118 120 Mon-Fri 9am – 5pm EST
Credit card details:
Visa
To: PO Box 67 St Leonards NSW 1590
Mastercard
Number
Expiry _____/_____ Amount $
Cardholder Name
*25% Discount offer for new customers only. Offer expires 30th April 2012.
Date:
Signature
Amount
$